Machine Learning-Based Bioactivity Prediction of Potential PPAR-γ Agonists for the Management of Diabetes
Madhwani, J.; Sankranarayanan, M.
Show abstract
This research paper presents a machine learning approach to predict bioactivity of compounds that can act as PPAR-gamma agonist, a critical target for diabetes treatment. Using data from the ChEMBL database, molecular descriptors were calculated and a Random Forest model was developed, achieving an R2 score of 0.83. Key molecular features influencing bioactivity were identified, and a web application was created for real-time predictions. This approach demonstrates how computational methods can accelerate drug discovery for diabetes treatment.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 97%
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 96%
- Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors 96%
Similar papers in this journal
- Target2DeNovoDrugPropMax : a novel programmatic tool incorporating deep learning and in silico methods for automated de novo drug design for any target of interest 97%
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 97%
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 96%
Similar papers in this journal
- DenovoProfiling: a webserver for de novo generated molecule library profiling 95%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 94%
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations 93%
Similar papers in this journal
- Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-based Classifiers 97%
- Support Vector Machine based prediction models for drug repurposing and designing novel drugs for colorectal cancer 97%
- Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design 95%
Similar papers in this journal
- PeruNPDB: The Peruvian Natural Products Database for in silico drug screening 95%
- Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy 95%
- A new strategy for identifying mechanisms of drug-drug interaction using transcriptome analysis: Compound Kushen injection as a proof of principle 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.